Tetra Bio-Pharma Company Description

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of immunomodulator drugs.

The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; and REBORN for the treatment of breakthrough cancer pain.

It also develops novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute Respiratory Distress Syndrome, sepsis and ophthalmic disease.

The company is headquartered in Orléans, Canada.

Tetra Bio-Pharma Inc.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
Employees	33

Contact Details

Address: 2316 St. Boulevard Orléans, ON K1C 1E8 Canada
Website	tetrabiopharma.com

Stock Details

Ticker Symbol	TBPMQ
Exchange	OTCMKTS
Share Class	Class A Shares
Fiscal Year	December - November
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Richard Giguere	Chief Executive Officer of Tetra Natural Health Inc.
Steeve Néron	Chief Commercial Officer
André Rancourt B.Sc.	Co-Founder
Leslie Auld C.A., CPA, M.B.A.	Chief Financial Officer
Jennifer McCaughey	Vice President of Investor Relations
Dania Scott B.Sc.	Senior Vice President of Commercial Strategy
Aurelia De Pauw	Senior Vice President of Clinical Programs and Medical Affairs
Randy Ringuette	Project Director and Member of Advisory Board
Chris MacLean	Chief Operating Officer of Tetra Natural Health